Idom (Dosulepin Hydrochloride)

• Dosulepin, a tricyclic antidepressant, acts on the monoamine neurotransmitter system to treat mood disorders.
• Depressive disorders: alleviates symptoms of major depressive episodes, improving mood and energy levels.
• Anxiety disorders: reduces excessive worry and physical tension associated with generalized anxiety.
• Panic disorder: helps prevent recurrent panic attacks by stabilizing neurotransmitter levels.

• Dosulepin inhibits the reuptake of norepinephrine and serotonin at neuronal synapses, increasing their extracellular concentrations. By blocking the presynaptic transporters for these monoamines, it enhances neurotransmission in central pathways that regulate mood and anxiety. The drug also possesses mild antagonistic activity at histamine H1 and muscarinic receptors, contributing to its overall pharmacological profile.

Dosulepin may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects

• Dry mouth: reduced salivation leading to throat discomfort.
• Drowsiness: increased sedation, especially at treatment initiation.
• Constipation: slowed gastrointestinal motility causing infrequent stools.
• Weight gain: gradual increase in body weight during therapy.

Serious or Rare Side Effects

• Cardiac arrhythmias: irregular heart rhythms that may be life‑threatening.
• Seizures: risk of convulsive episodes, particularly in predisposed individuals.
• Severe hypotension: sudden drop in blood pressure causing dizziness or fainting.

When prescribing Dosulepin, clinicians should consider several safety measures.

• Cardiovascular assessment: evaluate heart function before initiating therapy due to risk of arrhythmias.
• Suicidal ideation monitoring: observe patients for worsening depression or suicidal thoughts, especially early in treatment.
• Drug interactions: review concomitant medications for serotonergic or anticholinergic effects.
• Pregnancy and lactation: use only if benefits outweigh potential risks; consult obstetric specialist.
• Store at ambient temperature: keep below 25°C in original packaging, protect from moisture and light.

Dosulepin can interact with various medicines, requiring careful management.

Major Interactions (Avoid)

• MAO inhibitors: concurrent use can cause hypertensive crisis or serotonin syndrome.
• Selective serotonin reuptake inhibitors (SSRIs): combined therapy increases risk of serotonin syndrome.
• CYP2D6 inhibitors (e.g., quinidine): may raise dosulepin plasma levels leading to toxicity.

Moderate Interactions (Monitor Closely)

• Anticholinergic agents: additive dry mouth and constipation.
• Beta‑blockers: may enhance bradycardic effects.